Literature DB >> 15271193

Ciclopirox: a broad-spectrum antifungal with antibacterial and anti-inflammatory properties.

Aditya K Gupta1, Todd Plott.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15271193     DOI： 10.1111/j.1461-1244.2004.02380.x

Source DB:  PubMed          Journal:  Int J Dermatol        ISSN： 0011-9059            Impact factor:   2.736


× No keyword cloud information.
  12 in total

1.  Preclinical Pharmacokinetics of Fosciclopirox, a Novel Treatment of Urothelial Cancers, in Rats and Dogs.

Authors:  Scott J Weir; Robyn Wood; Karl Schorno; Amanda E Brinker; Prabhu Ramamoorthy; Kathy Heppert; Lian Rajewski; Mehmet Tanol; Tammy Ham; Michael J McKenna; William McCulloch; Michael Dalton; Gregory A Reed; Roy A Jensen; Michael J Baltezor; Shrikant Anant; John A Taylor
Journal:  J Pharmacol Exp Ther       Date:  2019-05-21       Impact factor: 4.030

Review 2.  Repositioning the Old Fungicide Ciclopirox for New Medical Uses.

Authors:  Tao Shen; Shile Huang
Journal:  Curr Pharm Des       Date:  2016       Impact factor: 3.116

Review 3.  Mechanistic Insights of Formulation Approaches for the Treatment of Nail Infection: Conventional and Novel Drug Delivery Approaches.

Authors:  Agrawal Vikas; Patel Rashmin; Patel Mrunali; Rahul B Chavan; Thanki Kaushik
Journal:  AAPS PharmSciTech       Date:  2020-01-14       Impact factor: 3.246

4.  Effect of pH on in vitro susceptibility of Candida glabrata and Candida albicans to 11 antifungal agents and implications for clinical use.

Authors:  Claire S Danby; Dina Boikov; Rina Rautemaa-Richardson; Jack D Sobel
Journal:  Antimicrob Agents Chemother       Date:  2012-01-09       Impact factor: 5.191

Review 5.  Ciclopirox: recent nonclinical and clinical data relevant to its use as a topical antimycotic agent.

Authors:  Alessandro Subissi; Daniela Monti; Giuseppe Togni; Federico Mailland
Journal:  Drugs       Date:  2010-11-12       Impact factor: 9.546

6.  Chemical Constituents and an Alternative Medicinal Veterinary Herbal Soap Made from Senna macranthera.

Authors:  Flávia Inoue Andrade; Gislaine Aparecida Purgato; Thalita de Faria Maia; Raoni Pais Siqueira; Sâmia Lima; Gaspar Diaz; Marisa Alves Nogueira Diaz
Journal:  Evid Based Complement Alternat Med       Date:  2015-03-03       Impact factor: 2.629

Review 7.  Amorolfine vs. ciclopirox - lacquers for the treatment of onychomycosis.

Authors:  Katarzyna Tabara; Anna E Szewczyk; Wojciech Bienias; Agnieszka Wojciechowska; Marta Pastuszka; Magdalena Oszukowska; Andrzej Kaszuba
Journal:  Postepy Dermatol Alergol       Date:  2015-02-03       Impact factor: 1.837

Review 8.  Ciclopirox Hydroxypropyl Chitosan (HPCH) Nail Lacquer: A Review of Its Use in Onychomycosis.

Authors:  Bianca Maria Piraccini; Matilde Iorizzo; André Lencastre; Pietro Nenoff; Dimitris Rigopoulos
Journal:  Dermatol Ther (Heidelb)       Date:  2020-07-23

9.  Inhibition of HIV-1 gene expression by Ciclopirox and Deferiprone, drugs that prevent hypusination of eukaryotic initiation factor 5A.

Authors:  Mainul Hoque; Hartmut M Hanauske-Abel; Paul Palumbo; Deepti Saxena; Darlene D'Alliessi Gandolfi; Myung Hee Park; Tsafi Pe'ery; Michael B Mathews
Journal:  Retrovirology       Date:  2009-10-13       Impact factor: 4.602

10.  Improving the Pharmacological Properties of Ciclopirox for Its Use in Congenital Erythropoietic Porphyria.

Authors:  Ganeko Bernardo-Seisdedos; Jorge M Charco; Itxaso SanJuan; Sandra García-Martínez; Pedro Urquiza; Hasier Eraña; Joaquín Castilla; Oscar Millet
Journal:  J Pers Med       Date:  2021-05-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.